News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
769,649 Results
Type
Article (69275)
Company Profile (403)
Press Release (699946)
Multimedia
Podcasts (184)
Webinars (32)
Section
Business (209913)
Career Advice (2463)
Deals (35847)
Drug Delivery (152)
Drug Development (85751)
Employer Resources (156)
FDA (16808)
Job Trends (15380)
News (356427)
Policy (33118)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2925)
Academic (2)
Accelerated approval (43)
Adcomms (27)
Allergies (171)
Alliances (53697)
ALS (211)
Alzheimer's disease (1862)
Antibody-drug conjugate (ADC) (435)
Approvals (17112)
Artificial intelligence (698)
Autoimmune disease (255)
Automation (53)
Bankruptcy (338)
Best Places to Work (11650)
BIOSECURE Act (19)
Biosimilars (212)
Biotechnology (258)
Bladder cancer (176)
Brain cancer (72)
Breast cancer (716)
Cancer (5673)
Cardiovascular disease (482)
Career advice (2099)
Career pathing (46)
CAR-T (327)
CDC (53)
Celiac Disease (1)
Cell therapy (892)
Cervical cancer (44)
Clinical research (73257)
Collaboration (2157)
Company closure (6)
Compensation (1225)
Complete response letters (86)
COVID-19 (2900)
CRISPR (111)
C-suite (1079)
Cystic fibrosis (160)
Data (7384)
Decentralized trials (3)
Denatured (66)
Depression (176)
Dermatology (70)
Diabetes (559)
Diagnostics (6996)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (350)
Drug pricing (217)
Drug shortages (32)
Duchenne muscular dystrophy (264)
Earnings (88597)
Editorial (67)
Employer branding (21)
Employer resources (142)
Events (121953)
Executive appointments (1111)
FDA (20384)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1740)
Gene editing (237)
Generative AI (73)
Gene therapy (723)
GLP-1 (1108)
Government (4641)
Grass and pollen (7)
Guidances (402)
Healthcare (19053)
HIV (75)
Huntington's disease (54)
IgA nephropathy (98)
Immunology and inflammation (298)
Immuno-oncology (93)
Indications (163)
Infectious disease (3235)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (136)
Intellectual property (282)
Interviews (443)
IPO (16744)
IRA (59)
Job creations (4100)
Job search strategy (1751)
JPM (69)
Kidney cancer (18)
Labor market (86)
Layoffs (594)
Leadership (40)
Legal (7886)
Liver cancer (101)
Longevity (29)
Lung cancer (749)
Lymphoma (416)
Machine learning (56)
Management (52)
Manufacturing (1023)
MASH (193)
Medical device (13854)
Medtech (13939)
Mergers & acquisitions (20316)
Metabolic disorders (1484)
mRNA (217)
Multiple sclerosis (182)
NASH (22)
Neurodegenerative disease (422)
Neuropsychiatric disorders (111)
Neuroscience (3389)
Neurotech (1)
NextGen: Class of 2026 (6631)
Non-profit (4730)
Now hiring (63)
Obesity (696)
Opinion (337)
Ovarian cancer (202)
Pain (251)
Pancreatic cancer (278)
Parkinson's disease (370)
Partnered (37)
Patents (582)
Patient recruitment (639)
Peanut (62)
People (62356)
Pharmaceutical (102)
Pharmacy benefit managers (30)
Phase 1 (22843)
Phase 2 (32106)
Phase 3 (23931)
Pipeline (7584)
Policy (330)
Postmarket research (2961)
Preclinical (10250)
Press Release (72)
Prostate cancer (294)
Psychedelics (59)
Radiopharmaceuticals (339)
Rare diseases (1093)
Real estate (6423)
Recruiting (67)
Regulatory (25789)
Reports (45)
Research institute (2721)
Resumes & cover letters (371)
Rett syndrome (35)
RNA editing (21)
RSV (89)
Schizophrenia (181)
Series A (291)
Series B (213)
Service/supplier (16)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (175)
Sponsored (51)
Startups (3933)
State (2)
Stomach cancer (18)
Supply chain (125)
Tariffs (99)
The Weekly (115)
Vaccines (1156)
Venture capital (102)
Weight loss (459)
Women's health (110)
Worklife (22)
Date
Today (20)
Last 7 days (639)
Last 30 days (2462)
Last 365 days (31298)
2026 (9460)
2025 (31483)
2024 (36357)
2023 (41143)
2022 (52377)
2021 (56836)
2020 (54948)
2019 (47427)
2018 (36060)
2017 (34454)
2016 (34473)
2015 (40624)
2014 (34272)
2013 (30495)
2012 (31390)
2011 (31468)
2010 (29984)
Location
Africa (991)
Alabama (100)
Alaska (7)
Arizona (308)
Arkansas (16)
Asia (46749)
Australia (7992)
California (12544)
Canada (3574)
China (1342)
Colorado (549)
Connecticut (568)
Delaware (382)
Europe (105124)
Florida (1904)
Georgia (402)
Hawaii (3)
Idaho (53)
Illinois (1005)
India (90)
Indiana (568)
Iowa (21)
Japan (522)
Kansas (136)
Kentucky (47)
Louisiana (39)
Maine (80)
Maryland (1538)
Massachusetts (9145)
Michigan (377)
Minnesota (706)
Mississippi (7)
Missouri (148)
Montana (36)
Nebraska (29)
Nevada (138)
New Hampshire (82)
New Jersey (3489)
New Mexico (33)
New York (3346)
North Carolina (1695)
North Dakota (9)
Northern California (6168)
Ohio (381)
Oklahoma (24)
Oregon (43)
Pennsylvania (2530)
Puerto Rico (29)
Rhode Island (47)
South America (1292)
South Carolina (84)
South Dakota (1)
Southern California (4942)
Tennessee (200)
Texas (1997)
United States (45102)
Utah (386)
Vermont (1)
Virginia (320)
Washington D.C. (84)
Washington State (1044)
West Virginia (3)
Wisconsin (140)
Wyoming (2)
769,649 Results for "johnson and johnson pharmaceutical research and development llc nj".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson’s DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers
March 27, 2026
·
10 min read
Press Releases
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
April 14, 2026
·
19 min read
Press Releases
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 16, 2026
·
1 min read
Press Releases
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
January 8, 2026
·
4 min read
Press Releases
Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch
March 16, 2026
·
6 min read
Press Releases
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
April 7, 2026
·
7 min read
Press Releases
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
·
1 min read
Press Releases
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
·
10 min read
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.
March 25, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)
March 3, 2026
·
10 min read
1 of 76,965
Next
